CA2984437C - COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS - Google Patents

COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS

Info

Publication number
CA2984437C
CA2984437C CA2984437A CA2984437A CA2984437C CA 2984437 C CA2984437 C CA 2984437C CA 2984437 A CA2984437 A CA 2984437A CA 2984437 A CA2984437 A CA 2984437A CA 2984437 C CA2984437 C CA 2984437C
Authority
CA
Canada
Prior art keywords
cys
seq
glu leu
tyr
pro ala
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2984437A
Other languages
English (en)
French (fr)
Other versions
CA2984437A1 (en
Inventor
Mark G. Currie
Robert Solinga
Christopher Leitheiser
Original Assignee
Ironwood Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ironwood Pharmaceuticals Inc filed Critical Ironwood Pharmaceuticals Inc
Priority to CA3172777A priority Critical patent/CA3172777A1/en
Publication of CA2984437A1 publication Critical patent/CA2984437A1/en
Application granted granted Critical
Publication of CA2984437C publication Critical patent/CA2984437C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA2984437A 2015-05-01 2016-04-29 COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS Active CA2984437C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3172777A CA3172777A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562156077P 2015-05-01 2015-05-01
US62/156,077 2015-05-01
PCT/US2016/030061 WO2016178979A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA3172777A Division CA3172777A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Publications (2)

Publication Number Publication Date
CA2984437A1 CA2984437A1 (en) 2016-11-10
CA2984437C true CA2984437C (en) 2025-11-18

Family

ID=55953439

Family Applications (2)

Application Number Title Priority Date Filing Date
CA2984437A Active CA2984437C (en) 2015-05-01 2016-04-29 COMPOSITION FOR COLON CLEANSING AND THE TREATMENT OF GASTROINTESTINAL DISORDERS
CA3172777A Pending CA3172777A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Family Applications After (1)

Application Number Title Priority Date Filing Date
CA3172777A Pending CA3172777A1 (en) 2015-05-01 2016-04-29 Compositions for colon cleansing and the treatment of gastrointestinal disorders

Country Status (23)

Country Link
US (2) US10618938B2 (enExample)
EP (2) EP4218789A3 (enExample)
JP (5) JP6930919B2 (enExample)
KR (2) KR102783759B1 (enExample)
CN (2) CN114716514A (enExample)
CA (2) CA2984437C (enExample)
CY (1) CY1126031T1 (enExample)
DK (1) DK3288578T5 (enExample)
EA (1) EA201792401A1 (enExample)
ES (1) ES2947591T3 (enExample)
FI (1) FI3288578T3 (enExample)
HR (1) HRP20230381T1 (enExample)
HU (1) HUE061954T2 (enExample)
LT (1) LT3288578T (enExample)
MA (1) MA41985B1 (enExample)
MD (1) MD3288578T2 (enExample)
MX (2) MX2017013928A (enExample)
PL (1) PL3288578T3 (enExample)
PT (1) PT3288578T (enExample)
RS (1) RS64160B1 (enExample)
SI (1) SI3288578T1 (enExample)
SM (1) SMT202300114T1 (enExample)
WO (1) WO2016178979A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102783759B1 (ko) * 2015-05-01 2025-03-21 아이언우드 파마슈티컬스, 인코포레이티드 결장 세정을 위한 조성물 및 위장 장애의 치료
SMT202200173T1 (it) 2016-06-01 2022-05-12 Athira Pharma Inc Composti
EP4436980A1 (en) * 2021-11-24 2024-10-02 Ironwood Pharmaceuticals, Inc. Synthetic process for production of modified gcc receptor agonists
MX2024006317A (es) * 2021-11-24 2024-06-19 Ironwood Pharmaceuticals Inc Proceso sintetico para la produccion de agonistas del receptor de guanilato ciclasa c (gcc) modificados.
EP4440595A1 (en) * 2021-11-29 2024-10-09 Ironwood Pharmaceuticals, Inc. Pharmaceutical compositions for the treatment of visceral pain

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689139A5 (de) 1995-04-03 1998-10-30 Cerbios Pharma Sa Verfahren zur Herstellung einer liposomalen, in Wasser dispergierbaren, oral zu verabreichenden, festen, trockenen therapeutischen Formulierung.
US5912014A (en) 1996-03-15 1999-06-15 Unigene Laboratories, Inc. Oral salmon calcitonin pharmaceutical products
DE602004028678D1 (de) * 2003-01-28 2010-09-23 Ironwood Pharmaceuticals Inc Zusammensetzungen zur Behandlung von Magen-Darm-Störungen
US7494979B2 (en) * 2003-06-13 2009-02-24 Ironwood Pharmaceuticals, Inc. Method for treating congestive heart failure and other disorders
CA2619650A1 (en) * 2005-08-19 2007-02-22 Microbia, Inc. Methods and compositions for the treatment of gastrointestinal disorders
EP2331561A4 (en) * 2008-09-03 2013-02-27 Xenome Ltd PEPTIDE CONJUGATE LIBRARIES AND METHODS OF MAKING SAME
WO2011103311A2 (en) * 2010-02-17 2011-08-25 Ironwood Pharmaceuticals, Inc Treatments for gastrointestinal disorders
KR102034748B1 (ko) * 2011-03-01 2019-10-21 시너지 파마슈티컬즈 인코포레이티드 구아닐레이트 사이클라제 c 작용제의 제조 방법
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
EP4424697A3 (en) * 2013-06-05 2024-12-25 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
WO2016015055A1 (en) * 2014-07-25 2016-01-28 Ironwood Pharmaceuticals, Inc. Colon cleansing compositions
KR102783759B1 (ko) * 2015-05-01 2025-03-21 아이언우드 파마슈티컬스, 인코포레이티드 결장 세정을 위한 조성물 및 위장 장애의 치료

Also Published As

Publication number Publication date
RS64160B1 (sr) 2023-05-31
FI3288578T3 (fi) 2023-05-03
JP2025169325A (ja) 2025-11-12
HUE061954T2 (hu) 2023-09-28
DK3288578T3 (da) 2023-05-01
JP2022121734A (ja) 2022-08-19
SMT202300114T1 (it) 2023-05-12
WO2016178979A1 (en) 2016-11-10
HRP20230381T1 (hr) 2023-07-07
LT3288578T (lt) 2023-04-25
US20180148476A1 (en) 2018-05-31
BR112017023539A2 (pt) 2018-08-14
EA201792401A1 (ru) 2018-05-31
KR20250042844A (ko) 2025-03-27
CN108040482B (zh) 2022-03-29
KR102783759B1 (ko) 2025-03-21
SI3288578T1 (sl) 2023-07-31
JP6930919B2 (ja) 2021-09-01
MA41985B1 (fr) 2023-04-28
JP2024015335A (ja) 2024-02-01
CN108040482A (zh) 2018-05-15
CA2984437A1 (en) 2016-11-10
ES2947591T3 (es) 2023-08-11
CA3172777A1 (en) 2016-11-10
EP3288578A1 (en) 2018-03-07
MA41985A (fr) 2018-03-07
MX2017013928A (es) 2018-01-15
PL3288578T3 (pl) 2023-08-14
MX2022013283A (es) 2022-12-13
PT3288578T (pt) 2023-03-28
EP4218789A3 (en) 2023-09-27
KR20180005675A (ko) 2018-01-16
EP3288578B8 (en) 2023-03-29
US10618938B2 (en) 2020-04-14
EP4218789A2 (en) 2023-08-02
EP3288578B1 (en) 2023-03-15
CN114716514A (zh) 2022-07-08
MD3288578T2 (ro) 2023-08-31
US20240199697A1 (en) 2024-06-20
CY1126031T1 (el) 2023-11-15
JP2018519254A (ja) 2018-07-19
DK3288578T5 (da) 2024-10-07
JP2020203954A (ja) 2020-12-24

Similar Documents

Publication Publication Date Title
US20230340025A1 (en) Treatments for Gastrointestinal Disorders
AU2010314866B2 (en) Treatments for gastrointestinal disorders
US20240199697A1 (en) Compositions for Colon Cleansing and the Treatment of Gastrointestinal Disorders
US8735360B2 (en) Treatments for gastrointestinal disorders
HK40097176A (en) Compositions for colon cleansing and the treatment of gastrointestnal disorders
HK40080323A (en) Compositions for colon cleansing and the treatment of gastrointestinal disorders
EA048992B1 (ru) Композиции для очищения толстого кишечника и лечения желудочно-кишечных расстройств
BR112017023539B1 (pt) Peptídeos ou sais farmaceuticamente aceitáveis do mesmo, seus métodos de produção, seus usos e composições farmaceuticas

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415

EEER Examination request

Effective date: 20210415